Virginia Retirement Systems’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.03M Buy
63,103
+2,800
+5% +$42.3K 0.01% 573
2025
Q3
$705K Buy
60,303
+6,200
+11% +$80.8K ﹤0.01% 684
2025
Q2
$627K Sell
54,103
-20,700
-28% -$189K ﹤0.01% 703
2025
Q1
$653K Buy
+74,803
New +$943K ﹤0.01% 686
2023
Q3
Sell
-10,300
Closed -$575K 1036
2023
Q2
$575K Sell
10,300
-5,400
-34% -$292K 0.01% 691
2023
Q1
$876K Buy
15,700
+2,400
+18% +$112K 0.01% 574
2022
Q4
$485K Buy
13,300
+4,400
+49% +$144K 0.01% 832
2022
Q3
$253K Buy
+8,900
New +$339K ﹤0.01% 990

Other funds holding TXG

Virginia Retirement Systems's TXG Position: Q4 2025 in Review

Virginia Retirement Systems increased its 10x Genomics (TXG) stake by 4.6% in Q4 2025, buying an estimated $42.3K and bringing the position to 63,103 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #573.

Virginia Retirement Systems first reported a position in TXG in Q3 2022 and has held it in 8 quarters since. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Virginia Retirement Systems held 63,103 shares of 10x Genomics worth $1.03M as of Q4 2025.
  • Virginia Retirement Systems bought 2,800 10x Genomics shares in Q4 2025, an estimated $42.3K.
  • 10x Genomics made up 0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #573 holding.
  • Virginia Retirement Systems first reported a position in 10x Genomics in Q3 2022 and has held it in 8 quarters since.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.